You just read:

Longeveron LLC Announces Completion of Enrollment in Phase 2b Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Aging Frailty.

News provided by

Longeveron LLC

Feb 12, 2020, 12:05 ET